Back to Search Start Over

New Biomarkers Findings Has Been Reported by Investigators at Department of Cardiovascular Medicine (Plasma Renin Activity As a Marker for Predicting the Antihypertensive Effect of Switching To Sacubitril/valsartan In Treated Hypertensive...).

Source :
Hematology Week; 10/11/2024, p338-338, 1p
Publication Year :
2024

Abstract

A recent study conducted in Higashiosaka, Japan, explored the use of plasma renin activity (PRA) as a biomarker for predicting the antihypertensive effect of switching to sacubitril/valsartan (Sac/Val) in patients with treated hypertension. The study found that clinic blood pressure significantly decreased after switching to Sac/Val, and PRA before drug switching was significantly correlated with the change in systolic blood pressure. The researchers concluded that low PRA may be a useful marker for predicting the antihypertensive effect of switching to Sac/Val in treated hypertensive patients. This research has been peer-reviewed and published in The Journal of Clinical Hypertension. [Extracted from the article]

Details

Language :
English
ISSN :
1543673X
Database :
Complementary Index
Journal :
Hematology Week
Publication Type :
Periodical
Accession number :
180083845